Open AccessGastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR: A systematic literature review
Author(s) -
Michael S. Broder,
David O. Beenhouwer,
Jonathan Strosberg,
Maureen P. Neary,
Dasha Cherepanov
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i6.1945
Subject(s) - octreotide , neuroendocrine tumors , medicine , carcinoid tumors , gastroenterology , oncology , somatostatin
To review literature on efficacy and safety of octreotide-long-acting repeatable (LAR) used at doses higher than the Food and Drug Administration (FDA)-approved 30 mg/mo for treatment of neuroendocrine tumors (NETs).